Reni J. Benjamin

Reni J. Benjamin

Director/Board Member at Centre For Commercialization of Regenerative Medicine

Finance
Consumer Services
Health Technology

Profile

Dr. Reni J.
Benjamin
is an Equity Research Analyst at Citizens JMP Securities LLC.
He is on the Board of Directors at Centre For Commercialization of Regenerative Medicine.
He is covering biotechnology.
He currently serves on the advisory board of Phacilitate Cell & Gene Therapy.
Dr. Benjamin joins JMP Securities from Raymond James, where he was a managing director and senior research analyst.
Dr. Benjamin was previously a managing director at H.C.
Wainwright & Co. and Rodman & Renshaw, after starting his career in biotechnology research at Needham & Company.
He is a past member of the UAB School of Health Professions Dean's Advisory Board.
Dr. Benjamin holds a Ph.D.
in biochemistry and molecular genetics from the University of Alabama at Birmingham and a B.S.
in biology from Allegheny College.

Reni J. Benjamin active positions

CompaniesPositionStart
Analyst-Equity 01/08/2019
Director/Board Member -
All active positions of Reni J. Benjamin

Former positions of Reni J. Benjamin

CompaniesPositionEnd
Analyst-Equity 01/08/2019
Analyst-Equity 31/05/2015
Private Equity Analyst 31/07/2013
Analyst-Equity 01/06/2012
Analyst-Equity -
See the detail of Reni J. Benjamin's experience

Training of Reni J. Benjamin

The University of Alabama at Birmingham Doctorate Degree
Allegheny College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Reni J. Benjamin's experience

Connections

97

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies7

Finance

Finance

Finance

Finance

Finance

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Reni J. Benjamin